Roles of old players in the suppression of a new player: Networks for the transcriptional control of angiogenesis

Journal of Biochemistry

Volumn 149, Issue 2, 2011, Pages 117-119

  Watabe, Tetsuro ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

E2 2; HLH; Id1; SCL; TAL1; VEGFR2

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BONE MORPHOGENETIC PROTEIN; INHIBITOR OF DIFFERENTIATION 1; TRANSCRIPTION FACTOR E2 2; TRANSCRIPTION FACTOR TAL1; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; INTRACELLULAR SIGNALING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE MORPHOGENETIC PROTEINS; DIMERIZATION; GENE EXPRESSION REGULATION; HELIX-LOOP-HELIX MOTIFS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 79251499583     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvq146     Document Type: Review

References (17)

1. Pardali, E., Goumans, M. J., and ten Dijke, P. (2010) Signaling by members of the TGF-β family in vascular morphogenesis and disease. Trends Cell Biol. 20, 556-567
2. Kappel, A., Ronicke, V., Damert, A., Flamme, I., Risau, W., and Breier, G. (1999) Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice. Blood 93, 4284-4292
3. Lee, D., Park, C., Lee, H., Lugus, J. J., Kim, S. H., Arentson, E., Chung, Y. S., Gomez, G., Kyba, M., Lin, S., Janknecht, R., Lim, D. S., and Choi, K. (2008) ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification. Cell Stem Cell 2, 497-507
4. Itoh, F., Itoh, S., Goumans, M. J., Valdimarsdottir, G., Iso, T., Dotto, G. P., Hamamori, Y., Kedes, L., Kato, M., and ten Dijke, P. (2004) Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. EMBO J. 23, 541-551
5. Suzuki, Y., Montagne, K., Nishihara, A., Watabe, T., and Miyazono, K. (2008) BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo. J. Biochem. 143, 199-206
6. Suzuki, Y., Ohga, N., Morishita, Y., Hida, K., Miyazono, K., and Watabe, T. (2010) BMPs promote proliferation and migration of endothelial cells via stimulation of VEGF-A/VEGFR2 and angiopoietin-1/Tie2 signalling. J. Cell Sci. 123, 1684-1692
7. Miyazono, K. and Miyazawa, K. (2002) Id: a target of BMP signaling. Sci. STKE 2002, pe40
8. Miyazono, K., Kamiya, Y., and Morikawa, M. (2010) Bone morphogenetic protein receptors and signal transduction. J. Biochem. 147, 35-51
9. Perk, J., Iavarone, A., and Benezra, R. (2005) Id family of helix-loop-helix proteins in cancer. Nat. Rev. Cancer 5, 603-614
10. Lyden, D., Young, A. Z., Zagzag, D., Yan, W., Gerald, W., O'Reilly, R., Bader, B. L., Hynes, R. O., Zhuang, Y., Manova, K., and Benezra, R. (1999) Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401, 670-677
11. Valdimarsdottir, G., Goumans, M. J., Rosendahl, A., Brugman, M., Itoh, S., Lebrin, F., Sideras, P., and ten Dijke, P. (2002) Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation 106, 2263-2270
12. Visvader, J. E., Fujiwara, Y., and Orkin, S. H. (1998) Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev. 12, 473-479
13. Deleuze, V., Chalhoub, E., El-Hajj, R., Dohet, C., Le Clech, M., Couraud, P. O., Huber, P., and Mathieu, D. (2007) TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells. Mol. Cell. Biol. 27, 2687-2697
14. Tanaka, A., Itoh, F., Itoh, S., and Kato, M. (2009) TAL1/SCL relieves the E2-2-mediated repression of VEGFR2 promoter activity. J. Biochem. 145, 129-135
15. Tanaka, A., Itoh, F., Nishiyama, K., Takezawa, T., Kurihara, H., Itoh, S., and Kato, M. (2010) Inhibition of endothelial cell activation by bHLH protein E2-2 and its impairment of angiogenesis. Blood 115, 4138-4147
16. Terme, J. M., Lhermitte, L., Asnafi, V., and Jalinot, P. (2009) TGF-P induces degradation of TAL1/SCL by the ubiquitin-proteasome pathway through AKT-mediated phosphorylation. Blood 113, 6695-6698
17. Watabe, T., Nishihara, A., Mishima, K., Yamashita, J., Shimizu, K., Miyazawa, K., Nishikawa, S., and Miyazono, K. (2003) TGF-β receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells. J. Cell Biol 163, 1303-1311